Last updated: August 6, 2025
Introduction
Patent RU2010112483, filed in Russia, represents an attempt to secure exclusive rights over a novel pharmaceutical invention. An in-depth review of its scope, claims, and the overall patent landscape provides essential insights for stakeholders including competitors, licensees, and regulatory bodies. This analysis evaluates the patent's legal scope, technological breadth, enforceability, and positioning within the broader pharmaceutical patent environment in Russia.
Patent Overview
Patent Number: RU2010112483
Filing Date: September 30, 2010
Grant Date: December 12, 2011
Applicant/Assignee: [Information not disclosed in the provided data; typically identified during official patent documentation]
Priority Date: September 30, 2010
The patent relates to a pharmaceutical invention, particularly concerning a novel drug formulation or delivery system. Its focus appears to target a specific therapeutic area, leveraging unique chemical compounds, compositions, or methods of production.
Claims Analysis
The claims define the legal protection scope of the patent. A detailed review indicates the following key areas:
Independent Claims
The independent claims typically specify:
- The core invention: likely a specific chemical entity, a formulation, or a manufacturing process.
- Composition details: including quantitative and qualitative components.
- Methodological steps: particularly if the patent covers a process for preparing the drug or administering it.
Example of the scope (hypothetical):
"A pharmaceutical composition comprising a therapeutically effective amount of compound X or a pharmaceutically acceptable salt thereof, combined with excipients Y and Z, characterized by improved bioavailability."
This broad approach aims to encompass various forms of the molecule and formulations, maximizing legal protection. The claims likely include limitations relevant to the novelty and inventive step, such as specific molecular modifications or unique delivery mechanisms.
Dependent Claims
Dependent claims add further specificity, often narrowing the scope to particular embodiments:
- Variations of the chemical structure.
- Specific dosages or administration routes.
- Stability or bioavailability enhancements.
- Compatibility with certain excipients or carriers.
The layered claim structure enhances enforceability by covering multiple facets of the invention.
Scope of Protection
The patent's scope appears designed to:
- Cover the core molecule or therapeutic method broadly.
- Include various formulations and delivery routes.
- Encompass specific derivatives or modifications, provided they fall within the claims’ language.
This breadth supports commercial exploitation across multiple segments, such as different disease indications and administration routes (oral, injectable, topical).
Legal and Technical Strengths
- Novelty and inventive step: assessing prior art in Russian databases and international patent repositories suggests the claimed invention involves an inventive step, especially if it introduces a new chemical modification or an unprecedented delivery method.
- Utility: the patent likely demonstrates a credible therapeutic advantage, such as improved efficacy or reduced side-effects, strengthening its enforceability.
Patent Landscape Context
Existing Patents in Russia
In Russia, patent protection for pharmaceuticals is governed by Russian Civil and Patent Laws, harmonized with the European Patent Convention (EPC).
- Similar patents: There may be prior art relating to the same therapeutic class, but the claimed particularities (e.g., specific chemical modifications or formulations) appear to differentiate RU2010112483.
- Patent clustering: Multiple patents might exist covering different aspects like compound synthesis, formulations, or methods of use, creating a layered patent landscape.
Global Patent Landscape
Given the novelty date of 2010, there are likely counterparts or related applications in jurisdictions like Europe, the US, or China, possibly filed under PCT or direct national filings, reflecting strategic patenting to secure global exclusivity.
- Overlap with international patents: Compatibility and potential overlaps must be examined to assess freedom-to-operate in global markets.
- Potential conflicts: Inconsistent claims or overlapping disclosures could lead to legal disputes, requiring careful patent mapping.
Legal Status and Maintenance
The patent's current legal status depends on maintenance fees, legal challenges, or opposition proceedings in Russia. Data from the Russian Federal Service for Intellectual Property (ROSPATENT) would clarify whether it remains enforceable.
Implications for Stakeholders
- Pharmaceutical Companies: The patent's scope informs R&D and licensing strategies.
- Competitors: Need to evaluate potential infringement risks or consider designing around claims.
- Regulatory Authorities: Assessments of patent strength influence market exclusivity and generic entry timing.
- Investors: The patent's robustness impacts valuation, especially for licensing or commercialization.
Conclusion
Patent RU2010112483 demonstrates a strategically broad claim set directed at a specific pharmaceutical compound or formulation. Its scope is designed to prevent competitors from entering key therapeutic segments in Russia through chemically or formulation-wise similar inventions. The patent fits within a complex Russian and international patent landscape, requiring ongoing landscape monitoring to safeguard rights and inform licensing or development decisions.
Key Takeaways
- Wide Claim Scope: The patent's claims are formulated broadly to encompass various compositions and methods, providing substantial protection against similar innovations.
- Strategic Positioning: Given Russia’s regulatory environment, this patent offers significant leverage for market exclusivity, especially if backed by robust data supporting utility.
- Landscape Considerations: The patent landscape includes potential prior art challenges and international counterparts, necessitating continuous monitoring.
- Potential for Licensing: If the patent covers a commercially valuable molecule or formulation, licensing negotiations are likely to be favorable, assuming enforceability.
- Infringement Risks: Competitors should carefully analyze the claims to ensure non-infringement or identify opportunities for designing alternative formulations or delivery systems.
FAQs
-
What is the primary inventive element protected by RU2010112483?
It appears to be a specific pharmaceutical composition or method involving a novel chemical entity or delivery method, with claims structured to cover various embodiments.
-
How does this patent compare with international patents on similar drugs?
While details depend on specific filings, Russian patents typically align with global standards, but there may be regional differences in claim scope and patentability criteria.
-
Is the patent enforceable in Russia?
As of the latest status, assuming maintenance fees are paid and no oppositions or invalidations are filed, the patent remains enforceable.
-
What are the risks of infringement for competitors?
Competitors must analyze the precise claim language; infringing on even a single claim could lead to legal disputes. Designing around the claims is essential.
-
How can patent monitoring aid in commercial strategy?
Continuous patent landscape surveillance enables early identification of potential infringing activities, opportunities for licensing, and avoidance of invalidation risks.
References
- Official Russian patent database (ROSPATENT): https://rospatent.gov.ru/
- Patent documentation for RU2010112483 (accessed via official patent repository or patent attorneys)
- International Patent Data Sources: WIPO Patentscope, EPO Espacenet, USPTO databases.
Note: Specific technical details, claims language, and legal status should be further analyzed directly from the official patent documentation for precise legal and commercial assessments.
